Amalgamated Bank lifted its stake in shares of INC Research Holdings, Inc. (NASDAQ:INCR) by 54.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,836 shares of the company’s stock after acquiring an additional 2,765 shares during the period. Amalgamated Bank’s holdings in INC Research Holdings were worth $458,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of INCR. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of INC Research Holdings by 14.8% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock valued at $103,000 after acquiring an additional 228 shares during the last quarter. Invictus RG acquired a new stake in shares of INC Research Holdings during the first quarter valued at $115,000. Pacad Investment Ltd. acquired a new stake in shares of INC Research Holdings during the second quarter valued at $123,000. Foresters Investment Management Company Inc. acquired a new stake in shares of INC Research Holdings during the first quarter valued at $128,000. Finally, Riverhead Capital Management LLC acquired a new stake in shares of INC Research Holdings during the second quarter valued at $128,000. 54.56% of the stock is currently owned by institutional investors and hedge funds.

INC Research Holdings, Inc. (NASDAQ:INCR) opened at 53.55 on Friday. INC Research Holdings, Inc. has a 52-week low of $40.65 and a 52-week high of $61.10. The company’s 50-day moving average price is $54.97 and its 200 day moving average price is $53.16. The stock has a market capitalization of $2.90 billion, a P/E ratio of 32.81 and a beta of 1.34.

INC Research Holdings (NASDAQ:INCR) last issued its quarterly earnings results on Thursday, July 27th. The company reported $0.64 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.64. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The business had revenue of $258.10 million for the quarter, compared to the consensus estimate of $256.76 million. During the same quarter in the previous year, the company posted $0.61 earnings per share. INC Research Holdings’s revenue for the quarter was down .3% compared to the same quarter last year. On average, equities research analysts anticipate that INC Research Holdings, Inc. will post $2.62 earnings per share for the current year.

In other news, CEO Alistair Macdonald sold 8,828 shares of INC Research Holdings stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $55.65, for a total transaction of $491,278.20. Following the transaction, the chief executive officer now owns 110,629 shares in the company, valued at $6,156,503.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Gregory S. Rush sold 88,739 shares of INC Research Holdings stock in a transaction on Friday, September 1st. The shares were sold at an average price of $58.99, for a total value of $5,234,713.61. Following the transaction, the chief financial officer now owns 149,301 shares in the company, valued at approximately $8,807,265.99. The disclosure for this sale can be found here. Insiders have sold 198,321 shares of company stock worth $11,550,792 in the last quarter. 0.24% of the stock is currently owned by corporate insiders.

INCR has been the topic of a number of analyst reports. TheStreet lowered INC Research Holdings from a “b” rating to a “c” rating in a research note on Friday, July 28th. BidaskClub downgraded INC Research Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Jefferies Group LLC reiterated a “buy” rating and set a $62.00 target price on shares of INC Research Holdings in a research report on Friday, June 16th. William Blair downgraded INC Research Holdings from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 20th. Finally, Mizuho initiated coverage on INC Research Holdings in a research report on Thursday, September 21st. They set a “neutral” rating and a $57.00 target price on the stock. Six research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. INC Research Holdings currently has an average rating of “Hold” and an average target price of $62.81.

WARNING: This news story was posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/amalgamated-bank-has-458000-position-in-inc-research-holdings-inc-incr/1611917.html.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.